About the LIGHTWAVE Study The clinical research study lasts up to 20 weeks, with up to 7 visits to the study site and 2 phone check-ins. Additionally, there will be assessments done using a mobile device between visits. The investigational drug is a capsule taken...

Several treatments are available to help ease Alzheimer’s symptoms; however, none of these existing treatments are capable of slowing the progression of the disease and protecting the brain from further damage. Clinical researches are developing new treatments that may slow the progression of Alzheimer’s. The SUVN-502...